The evidence described above suggested that the HMGCR inhibitor enhanced the FXR overexpression-mediated decreases in migration, adhesion, invasion and angiogenesis via the inhibition of cholesterol synthesis in human bladder cancer cells. The gene discussed is HMGCR; the disease is urinary bladder cancer.